A comparison of angiographic and clinical outcomes after sirolimus-eluting versus paclitaxel-eluting stents for the treatment of in-stent restenosis

Chinese Medical Journal

Volumn 119, Issue 13, 2006, Pages 1059-1064

  Li, Jian Jun ^a   Xu, Bo ^a   Yang, Yue Jin ^a   Ma, Wei Hua ^a   Chen, Ji Lin ^a   Qiao, Shu Bing ^a   Qin, Xue Wen ^a   Yao, Min ^a   Liu, Hai Bo ^a   Wu, Yong Jian ^a   Yuan, Jin Qing ^a   Chen, Jue ^a   You, Shi Jie ^a   Dai, Jun ^a   Xia, Ran ^a   Gao, Run Lin ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Angiography; Coronary artery disease; Drug eluting stent; Restenosis

Indexed keywords

CLOPIDOGREL; HEPARIN; PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; CORONARY STENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SAMPLE SIZE; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 33746106008     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200607010-00001     Document Type: Article

References (20)

1. Alfonso F, Zueco J, Cequler A, Mantilla R, Bethencourt A, Lopez-Minguez JR, et al. A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis. J Am Coll Cardiol 2003;42:796-805.
2. Bauters C, Banos JL, Van Belle E, Mc Fadden EP, Lablanche JM, Bertrand ME, et al. Six-month angiographic outcome after successful repeat percutaneous intervention for in-stent restenosis. Circulation 1998;97:318-321.
3. Mahdi NA, Pathan AZ, Harrell L, Leon MN, Lopez J, Butte A, et al. Directional coronary atherectomy for the treatment of Palmaz-Schatz in-stent restenosis. Am J cardiol 1998;82:1345-1351.
4. Mehran R, Dangas G, Mintz GS, White RL, Chan RC, Gierlach LM, et al. Treatment of in-stent restenosis with excimer laser coronary angioplasty versus rotational atherectomy: comparative mechanisms and results. Circulation 2000;101:2484-2489.
5. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 1999;100:1872-1878.
6. Lowe HC, Oesterle SN, Khachigian LM. Coronary in-stent restenosis: current status and future strategies. J Am Coll Cardiol 2002;39:183-193.
7. Sousa JE, Costa MA, Abizaid A, Sousa AGMR, Feres F, Mattos LA, et al. Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2003;107:24-27.
8. Tanabe K, Serruys PW, Grube E, Smits PC, Selbach G, van der Giessen WJ, et al. TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation. Circulation 2003;107:559-564.
9. Degertekin M, Regar E, Tanabe K, Smits P, van der Giessen WJ, Carlier SG, et al. Sirolimus-eluting stent for treatment of complex in-stent restenosis. J Am Coll Cardioll 2003;41:184-189.
10. Commeau P, Barragan PT, Roquebert PO, Simeoni JB. ISR II study: a long-term evaluation of sirolimus-eluting stent in the treatment of patients with in-stent restenotic native coronary artery lesions. Catheter Cardiovasc Inter 2005;66:158-162.
11. Rahe B, Suttorp MJ, Te Riele HA, Bal ET, Ernst SM, Mast EG, et al. Stenting for restenotic lesions with the BARD XT stent. J Interven Cardiol 2003;16:227-230.
12. Schiele TM, Konig AK, Rieber J, Erhard I, Leibig M, Theisen K, et al. Sirolimus-eluting stent implantation and (-irradiation for the treatment of in-stent restenotic lesions: comparison of underlying mechanisms of acute gain and late loss as assessed by volumetric intravascular ultrasound. Am Heart J 2005;150:351-357.
13. Kastrati A, Mehilli J, von Beckerath N, Dibra A, Hausleiter J, Pache J, et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trail. JAMA 2005;293:165-171.
14. Neumann FJ, Desmet W, Grube E, Brachmann J, Presbitero P, Rubartelli P, et al. Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement. Circulation 2005;111:2107-2111.
15. Hill RA, Dundar Y, Bakhai A, Dickson R, Walley T. Drug-eluting stents: an early systematic review to inform policy. Eur Heart J 2004;25:902-919.
16. Colombo A. The 0% restenosis study. Ital Heart J 2002;3:559-561.
17. Xu B, Li JJ, Yang YJ, Ma WH, Chen JL, Qiao SB, et al. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients. Chin Med J 2006; 119: 533-538.
18. Colombo A, Lakovou I. Drug-eluting stents: the new gold standard for percutaneous coronary revascularization. Eur Heart J 2004;25:895-897.
19. Goy JJ, Stauffer JC, Siegenthaler M, Benoit A, Seydoux C. A prospective randomized comparison between paclitaxel and sirolimus stents in the real world of interventional cardiology: the TAXI trial. J Am Coll Cardiol 2005;45:308-311.
20. Babapulle MN, Joseph L, Belisle P, Brophy JM, Eisenberg ML. A hierachical Bayesian meta-analysis of randomized clinical trials of drug-eluting stents. Lancet 2004;364:583-591.